Form D · Other
Orion Nutraceuticals Inc.
Vancouver, A1 · CIK 0001822518
Offering snapshot reported Aug 26, 2020 · SEC filing
- Reported sold
- $110K Offering amount: $110K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2020 | Initial | $110,313 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-374094
$150,000 CAD converted to USD based on conversion rate of $0.73542 as of July 10, 2020.
Source: Form D, filed Aug 26, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Dumaresq | Director, Executive |
| Sam Jenkins | Director |
| Robin Linden | Director |
| Kevin Taylor | Director |
Issuer details
Industry: Other (See others in industry)
Address:
810 789 West Pender Street
Vancouver, A1, V6C1H2
Vancouver, A1, V6C1H2